Approach to the use of Glucocorticoids in Pregnancy for Nonobstetric Indications

de Swiet's Medical Disorders in Obstetric Practice: Fifth Edition

Volumn , Issue , 2010, Pages 736-741

  Chen, Kenneth K ^a   Powrie, Raymond O ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Glucocorticoid safety in pregnancy; Glucocorticoids, and insulin resistance unmasking impaired glucose tolerance in women at risk; Glucocorticoids, essential for life wide spectrum of effects on organ systems; HPA axis test administering synthetic analog of adrenocorticotropin hormone; Major surgical stress glucocorticoid target, 100 150 mg of hydrocortisone; Pproach to use of glucocorticoids in pregnancy for nonobstetric indications; Side effects of exogenous glucocorticoid use; Stress dose glucocorticoids at time of labor and delivery; Testing HPA axis by Cosyntropin (tetracosactide) test; WHO warrants stress dose steroids

Indexed keywords

EID: 84885805561     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444323016.ch47     Document Type: Chapter

References (50)

1. Sloboda DM, Challis JRG, Moss TJM, Newnham JP. Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharmaceuti Des 2005;11(11):1459-72.
2. Newnham JP, Moss TJM, Nitsos I, Sloboda DM. Antenatal corticosteroids: the good, the bad and the unknown. Curr Opin Obstet Gynaecol 2002;14:607-12.
3. Baxter H, Fraser FC. Production of congenital defects in offspring of female mice treated with cortisone. McGill Med J 1950;19:245-9.
4. Fainstat T. Cortisone induced congenital cleft palate in rabbits. Endocrinology 1954;55:502-8.
5. Pinsky L, DiGeorge AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 1965;147:402-3.
6. Walker B. Induction of cleft palate in rats with anti-inflammatory drugs. Teratology 1971;4:39-42.
7. Harris JWS, Ross IP. Cortisone therapy in early pregnancy: rela tion to cleft palate. Lancet 1956;1:1045-17.
8. Doig RK, Coltman O. Cleft palate following cortisone therapy in early pregnancy. Lancet 1956;2:730.
9. Sinykin MB, Kaplan H. Leukaemia in pregnancy. Am J Obstet Gynecol 1962;83:220-34.
10. Morris WI. Pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Aust NZ J Obstet Gynaecol 1969;9:136-44.
11. Nolan GH, Sweet RL, Laros RK, Roure CA. Renal cadaver transplantation followed by successful pregnancies. Obstet Gynecol 1974;43(5):732-9.
12. Cote CJ, Meuwissen HJ, Pickering R. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 1974;85:324-8.
13. Schatz M, Patterson R, Zeitz S, Rourke J, Melam H. Corticosteroid therapy for the pregnant asthmatic patient. JAMA 1975;233:804-7.
14. Tozman ECS, Urowitz MB, Gladman DD. Systemic lupus erythematosus and pregnancy. J Rheumatol 1980;7:624-32.
15. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 1981;71:552.
16. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on foetal outcome. Gastroenterology 1981;80:72-6.
17. Coulam CB, Zincke H, Sterioff S. Pregnancy after renal transplantation: estrogen secretion. Transplantation 1982;33:556.
18. Park-Wyllie L, Mazzota P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
19. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18:93-101.
20. Cowchock S. Prevention of fetal death in the antiphospholipid antibody syndrome. Lupus 1996;5(5):467-72.
21. Lockshin MD, Sammaritano LR. Corticosteroids during pregnancy. Scand J Rheumatol Scandinavian 1998;107:136-8.
22. Silver RM, Branch DW. Immunologic disorders. In: Creasy RK, Resnik R (eds) Maternal fetal medicine. WB Saunders, Philadelphia, 1999.
23. French NP, Hagan R, Evans S, et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-21.
24. Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birthweight and head circumference? Obstet Gynecol 2002;99:101-8.
25. Banks BA, Cnaan A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol 1999;181:709-17.
26. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behaviour. Am J Obstet Gynecol 2004;190:588-95.
27. Jackson JR, Kleeman S, Doerzbacher M, Lambers DS. The effect of glucocorticosteroid administration on foetal movements and biophysical profile scores in normal pregnancies. J Maternal Fetal Neonat Med 2003;13(1):50-3.
28. Doyle LW, Ford GW, Rickards AL, Kelly EA, Davis NM, Callanan C, et al. Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams. Paediatrics 2000;106(1):E2.
29. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Paediatrics 2000;105(6):E77.
30. Hasbargen U, Reber D, Versmold H, Schulze A. Growth and development of children to 4 years of age after repeated antenatal steroid administration. Eur J Paediatr 2001;160:552-5.
31. Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Lajic S. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol 2008;159:309-16.
32. Mathiesen ER, Christensen AB, Hellmuth E, et al. Insulin doses during glucocorticoid treatment for foetal lung maturation in diabetic pregnancy: test of an algorithm. Acta Obstet Gynaecol Scand 2002;81:835.
33. Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 2005;21(7):1075-84.
34. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol 2003;111:736-42.
35. Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999;93:392-5.
36. Silverman M, Sheffer A, Diaz P, et al. Prospective pregnancy outcome data in patients with newly diagnosed, mild persistent asthma treated with once-daily budesonide: 5-year results from the START study. Am J Respir Crit Care Med 2004;169:A91.
37. Namazy J, Schatz M, Long L, et al. Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth. J Allergy Clin Immunol 2004;113:427-32.
38. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 6th edn. Lippincott Williams and Wilkins, Philadelphia, 2002.
39. Coustan DR, Mochizuki TK. Handbook for prescribing medications during pregnancy, 3rd edn. Lippincott-Raven, Philadelphia, 1998.
40. Larimore WL, Petrie KA. Drug use during pregnancy and lacta tion. Primary Care 2000;27(1):35-53.
41. Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA 1952;149:1542-3.
42. Lewis L, Robinson RF, Yee J, et al. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone infusion. Ann Intern Med 1953;39:116-25.
43. Salem M, Tainsh RE, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage - a reassessment 42 years after emergence of a problem. Ann Surg 1994;219(4):416-25.
44. Axelrod L. Glucocorticoid therapy. Medicine 1976;55:39-63.
45. Kehlet H. Clinical course and hypothalamic-pituitaryadrenocor tical function in glucocorticoid-treated surgical patients. FADL's Forlag, Copenhagen, 1976.
46. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 1997;121(2):123-9.
47. Bromberg JS, Alfrey EJ, Barker CF, et al. Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 1991;51(2):385-95.
48. Udelsman R, Ramp J, Gallucci WT, et al. Adaptation during surgical stress - a re-evaluation of the role of glucocorticoids. J Clin Invest 1986;44:1377-81.
49. Udelsman R, Goldstein DS, Loriaux DL, Chrousos GP. Catecholamine-glucocorticoid interactions during surgical stress. J Surg Res 1987;43:539-45.
50. Chernow B, Alexander HR, Thompson WR, et al. The hormonal responses to surgical stress. Arch Intern Med 1987;147:1273-8.